Eduardo Henrique Bonini

ORCID: 0000-0002-0334-7718
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Infectious Diseases and Tuberculosis
  • Pharmaceutical studies and practices
  • Antibiotics Pharmacokinetics and Efficacy
  • Pharmacological Effects and Toxicity Studies
  • Mycobacterium research and diagnosis
  • Computational Drug Discovery Methods
  • Biotechnology and Related Fields
  • COVID-19 Clinical Research Studies
  • Science and Education Research
  • HIV/AIDS drug development and treatment

Centro Universitário de Araraquara
2016-2020

No large study has ever evaluated the efficacy, safety and tolerability of meropenem/clavulanate to treat multidrug- extensively drug-resistant tuberculosis (MDR- XDR-TB). The aim this observational was evaluate therapeutic contribution, effectiveness, profile added a background regimen when treating MDR- XDR-TB cases. Patients treated with meropenem/clavulanate-containing (n=96) showed greater drug resistance than those exposed meropenem/clavulanate-sparing (n=168): in former group more...

10.1183/13993003.02146-2015 article EN European Respiratory Journal 2016-03-10

No large study to date has ever evaluated the effectiveness, safety and tolerability of imipenem/clavulanate versus meropenem/clavulanate treat multidrug- extensively drug-resistant tuberculosis (MDR- XDR-TB). The aim this observational was compare therapeutic contribution added background regimens MDR- XDR-TB cases. 84 patients treated with imipenem/clavulanate-containing showed a similar median number antibiotic resistances (8 8) but more fluoroquinolone resistance (79.0% 48.9%,...

10.1183/13993003.00214-2016 article EN European Respiratory Journal 2016-04-13

A tuberculose (TB) é uma doença infectocontagiosa causada pela micobactéria do gênero Mycobacterium, sendo a espécie Mycobacterium tuberculosis (Mtb) mais comum. TB afeta principalmente os pulmões, mas pode afetar praticamente todos órgãos corpo. É das doenças que causa mortes no mundo, letal por um único agente infeccioso e acomete 1/3 da população mundial. Cerca de 10 milhões pessoas desenvolvem mundo todo dois morrem anualmente. Os objetivos deste trabalho são apresentar o histórico...

10.25061/2527-2675/rebram/2019.v22i2.678 article PT cc-by Revista Brasileira Multidisciplinar 2019-05-01

Evidence on effectiveness, safety, and tolerability of imipenem/clavulanate (IC) linezolid containing regimens to treat multidrug-resistant (MDR-) extensively drug-resistant tuberculosis (XDR-TB) is scarce. The aim this observational study evaluate the therapeutic contribution IC manage MDR/XDR-TB cases at reference centre São Paulo state, Brazil. Twelve patients (9 males, 1 HIV positive in antiretroviral treatment, 4 MDR, 8 XDR) were treated with IC, 11 them within linezolid-containing...

10.1016/j.rppnen.2016.06.006 article EN cc-by-nc-nd Revista Portuguesa de Pneumologia 2016-07-30

Introdução: A tuberculose (TB) afeta 1/3 da população mundial e cerca de 10 milhões pessoas desenvolvem TB a cada ano, resultando em mais dois mortes. Objetivos: O principal objetivo deste trabalho é apresentar um estudo do perfil epidemiológico Araraquara (SP) comparar o com os padrões doença no mundo, Américas, Brasil Estado São Paulo. Método: As pesquisas informações foram coletadas relatório anual Organização Mundial Saúde (OMS), Ministério Brasil, Secretaria Paulo, Municipal Serviço...

10.25061/2527-2675/rebram/2020.v23i2.780 article PT cc-by Revista Brasileira Multidisciplinar 2020-09-11
Coming Soon ...